跳至主要内容
临床试验/CTRI/2019/02/017642
CTRI/2019/02/017642已完成3 期

se of a short course of low-dose Pregabalin for the treatment of Restless Leg Syndrome (RLS) in patients with chronic liver disease

Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Adults (19-60 years of age) with liver cirrhosis and idiopathic restless leg syndrome will be included

排除标准

  • (i) Hemodynamic instability (ii) Recent ( <4 weeks) deterioration of liver function as evidence by new appearance or worsening of ascites or encephalopathy or jaundice, or reduction of urine output, or gastrointestinal bleeding (iii) Known case of peripheral neuropathy (iv) Uncontrolled systemic illness such as diabetes mellitus, chronic kidney disease, defined as estimated GFR <60ml/min, hypothyroidism or (v) Pregnancy

研究者

发起方
Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow India

相似试验